Efficacy of intravitreal injection of aflibercept 2 mg compared to oral spironolactone in acute central serous chorioretinopathy patients
Delta Journal of Ophthalmology · 2026-01 · 27 (1) · 60-69
DOI: 10.4103/djo.djo_41_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Delta Journal of Ophthalmology, online erschienen am 10.03.2026. Verfasst von Amin E. Nawar und 1 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
The aim of this study was to compare the efficacy of intravitreal injection of aflibercept 2 mg to oral spironolactone in acute central serous chorioretinopathy cases with subretinal fluid (SRF) of less than a 3-month duration. Patients and methods This is a prospective randomized study which included 40 eyes of 40 treatment naïve patients with acute central serous chorioretinopathy who were divided into two groups: group 1 which included 20 eyes of 20 patients who received intravitreal injection of aflibercept 2 mg based on pro-re-nata protocol and group 2 that included 20 eyes of 20 patients who received oral spironolactone 50 mg daily up to 12 months. Optical coherence tomography was performed for all cases at baseline and after 1, 3, 6, 9, and 12 months.
Results
In group 1, the central macular thickness (CMT) diminished significantly from 446±120.5 µm at baseline to 207.2±11.1 µm after 12 months ( P
Zitieren
APA
Nawar, A. E., & Mohsen, S. (2026). Efficacy of intravitreal injection of aflibercept 2 mg compared to oral spironolactone in acute central serous chorioretinopathy patients. Delta Journal of Ophthalmology, 27(1), 60-69. https://doi.org/10.4103/djo.djo_41_25
Vancouver
Nawar AE, Mohsen S. Efficacy of intravitreal injection of aflibercept 2 mg compared to oral spironolactone in acute central serous chorioretinopathy patients. Delta Journal of Ophthalmology. 2026;27(1):60-69. doi:10.4103/djo.djo_41_25
BibTeX
@article{Nawar2026,
author = {Nawar, Amin E. and Mohsen, Shorouk},
title = {Efficacy of intravitreal injection of aflibercept 2 mg compared to oral spironolactone in acute central serous chorioretinopathy patients},
journal = {Delta Journal of Ophthalmology},
year = {2026},
volume = {27},
number = {1},
pages = {60--69},
doi = {10.4103/djo.djo_41_25}
}
EUVIMED